<DOC>
	<DOCNO>NCT00451555</DOCNO>
	<brief_summary>The primary purpose study help answer follow research question : whether enzastaurin give together fulvestrant help patient breast cancer make tumor small disappear long .</brief_summary>
	<brief_title>Enzastaurin Plus Fulvestrant v . Placebo Plus Fulvestrant Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Female patient histologicaldocumented diagnosis locally advance metastatic breast cancer . The primary metastatic tumor must ER and/or PtR receptor positive . Note : Hormone receptor positivity define ER PtR great 10 fmol/mg biochemical assay 10 % positive cell immunohistochemistry Patients resistant AI therapy Females postmenopausal status Previous radiation therapy allow , limited Measurable nonmeasurable disease Have performance status 0 , 1 , 2 Eastern Cooperative Oncology Group ( ECOG ) scale Have adequate organ function Have estimate life expectancy least 24 week Must sign inform consent document Have prior treatment fulvestrant enzastaurin Are receive concurrent administration antitumor therapy , exception gonadotropinreleasing hormone ( GnRH ) antagonist . Have receive treatment within last 4 week drug receive regulatory approval indication time study entry Have receive supplemental estrogen progesterone within 4 week prior study entry Are HER2positive Are unable discontinue use anticoagulant Have hypercalcemia Have second primary malignancy clinically detectable time consideration study enrollment Have document central nervous system ( CNS ) metastases , symptomatic pulmonary lymphangitis , involvement 1/3 liver Have serious concomitant systemic disorder Have serious cardiac condition Are unwilling unable discontinue use carbamazepine , phenobarbital , phenytoin least 14 day prior study therapy Are unable swallow tablet .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>